Japan approves Forxiga to treat chronic kidney disease in patients with and without type-II diabetes
Forxiga is the first-ever approved medicine for the treatment of the disease in Japan
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
chronic kidney disease
Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes
It is a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR…
Lupin gets US FDA approval for Sevelamer Hydrochloride Tablets
They are indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialysis
JBCPL forays into nephrology segment in India with new division called RENOVA
JBCPL to launch seven products in the division that will focus on the management of hypertension in Chronic Kidney Disease to…
AstraZeneca gets US FDA nod for FARXIGA to treat chronic kidney disease
In DAPA-CKD Phase III trial, FARXIGA demonstrated reduction in the risk of the composite of worsening of renal function, end-stage…
Lupin gets USFDA approval for Sevelamer Carbonate Tablets
They are indicated for the control of serum phosphorus in adults and children six years of age and older with chronic kidney…
Dr Reddy’s launches Cinacalcet Tablets in US
They are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30
Diabetes drug, Dapagliflozin shows benefits in patients with CKD
The drug, on top of standard of care, reduced the composite measure of worsening of renal function or risk of cardiovascular (CV)…
US FDA denies approval for Tricida’s Veverimer
Veverimer (TRC101), a non-absorbed, orally-administered polymer, is designed to treat metabolic acidosis in patients with chronic…